I give a 1 in 100 chance that there's an FDA submission next week for mild/moderate. Sorry, just calling it like i see it. He's not even sure when the data will be released.

Also, if I had to guess, the statistically significant parameter is reduction in SAE's. That's why they keep touting it.

I think yesterday's PR was a feeble attempt to arrest the stock's decline. Luckily, it worked.

Hoping I'm off.